Amber Tong

2 days ago | bloomberg.com | Julia Fioretti |Amber Tong

Die KI-Pharmafirma METiS Pharmaceuticals plant einen Börsengang in Hongkong. Informierte Kreise sprechen von einem möglichen Erlös von bis zu 200 Millionen US-Dollar. Das chinesische Unternehmen arbeitet dem Vernehmen nach mit Beratern an einem Börsengang, der womöglich noch vor Ende des Jahres über die Bühne gehen könnte. Die Erörterungen laufen noch. Zeitpunkt und Umfang des Börsengangs könnten sich noch verändern, wie darüber informierte Personen Bloomberg sagten.

2 days ago | bloomberg.com | Julia Fioretti |Amber Tong

(Bloomberg) -- Artificial intelligence-driven drug firm METiS Pharmaceuticals is considering an initial public offering in Hong Kong to raise as much as $200 million, according to people familiar with the matter. The drug delivery and discovery company is working with advisers to arrange an IPO, potentially before the end of this year, the people said, asking not to be identified because the discussions aren’t public.

2 weeks ago | bloomberg.com | Amber Tong

(Bloomberg) -- WuXi AppTec Co.’s first-quarter revenue beat analyst expectations, helped by strong sales in the US even though the company has become a political target there. Shanghai-based WuXi reported 9.65 billion yuan ($1.32 billion) in group revenue from the first three months of 2025, according to filing on Monday. This was well ahead of the 8.6 billion yuan that analysts expected. WuXi provides contract research, development and manufacturing services to drugmakers around the world.

2 weeks ago | bloomberg.com | Amber Tong |Sangmi Cha

Medical laboratory research. Photographer: Akos Stiller/Bloomberg(Bloomberg) -- Akeso Inc. shares plunged as much as 19% in Hong Kong on Monday after preliminary data for its new cancer drug fell short of expectations despite outperforming a best-selling US rival. Chinese regulators approved Akeso’s drug, ivonescimab, to treat a broad group of lung cancer patients who have not received prior treatment, Akeso said in a statement Friday.

2 weeks ago | bloomberg.com | Amber Tong

(Bloomberg) -- Chinese metal miner CMOC Group Ltd. said its chairman and vice chairman have both resigned for personal reasons. The exit of Yuan Honglin, chairman and non-executive director, will become effective once CMOC gets approval to appoint additional directors at an upcoming shareholder meeting, it said in a filing to the Hong Kong stock exchange. The resignation of vice chairman and chief investment officer Li Chaochun has already taken effect, it said.